[Therapeutic outcome of onabotulinum toxin type A in patients with upper limb spasticity].

Horimoto, Yoshihiko; Inagaki, Aki; Yoshikawa, Mika; Kanbe, Kumi; Tanaka, Hajime; Ando, Reika; Hibino, Hiroaki; Tajima, Toshihisa; Fukagawa, Kazutoshi; Kabasawa, Hidehiro

Horimoto, Yoshihiko; Inagaki, Aki; Yoshikawa, Mika; Kanbe, Kumi; Tanaka, Hajime; Ando, Reika; Hibino, Hiroaki; Tajima, Toshihisa; Fukagawa, Kazutoshi; Kabasawa, Hidehiro.

Affiliation

Horimoto Y; Department of Neurology, Nagoya City Rehabilitation and Sports Centre.

Rinsho Shinkeigaku ; 55(8): 544-9, 2015.

Article in Ja | MEDLINE | ID: mdl-26211529

Subject(s)

Acetylcholine Release Inhibitors/therapeutic use; Botulinum Toxins, Type A/therapeutic use; Muscle Spasticity/drug therapy; Acetylcholine Release Inhibitors/administration & dosage; Adult; Aged; Aged, 80 and over; Botulinum Toxins, Type A/administration & dosage; Humans; Middle Aged; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Botulinum Toxins, Type A / Acetylcholine Release Inhibitors / Muscle Spasticity Limits: Adult / Aged / Aged80 / Humans / Middle aged Language: Ja Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google